Natalie Gilley
Family · Smithville, TNNPI 1093953911
Payments from drug & device makers
Across 185 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$725
- AbbVie$325
- Boehringer Ingelheim$227
- Amgen$226
- Johnson & Johnson$156
- Astellas Pharma US Inc$156
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,20897%
- Education$853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 42 | $725 |
| AbbVie | 20 | $325 |
| Boehringer Ingelheim | 12 | $227 |
| Amgen | 14 | $226 |
| Johnson & Johnson | 10 | $156 |
| Astellas Pharma US Inc | 5 | $156 |
| Exact Sciences | 8 | $154 |
| Pfizer | 8 | $145 |
| Lilly USA, LLC | 9 | $134 |
| Nestle Healthcare Nutrition Inc. | 6 | $120 |
| AstraZeneca(2 entities) | 7 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $103 |
| GSK | 6 | $101 |
| Corcept Therapeutics | 5 | $85 |
| Bayer | 3 | $61 |
| Novartis | 3 | $52 |
| Merck | 3 | $52 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Seqirus USA Inc | 2 | $39 |
| Cipher Pharmaceuticals US LLC | 1 | $33 |
| Phathom Pharmaceuticals, Inc. | 3 | $31 |
| Sanofi Pasteur Inc. | 2 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Boston Scientific | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Tempus AI, Inc | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $16 |
| Insulet Corporation | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
How this compares
$3,293 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 50 | $58,817 |
| JardianceEmpagliflozin | 38 | $37,476 |
| XareltoRivaroxaban | 37 | $36,832 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 50 | $32,884 |
| EliquisApixaban | 25 | $18,842 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $14,822 |
| LinzessLinaclotide | 13 | $7,814 |
| Emgality PenGalcanezumab-Gnlm | 11 | $7,118 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $6,261 |
| TradjentaLinagliptin | 12 | $5,668 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,257 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 24 | $4,243 |
| Atorvastatin Calcium | 309 | $3,877 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 103 | $3,682 |
| Omeprazole | 232 | $3,054 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $725 | $58,81750 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta | $227 | $49,40564 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $101 | $37,14161 claims |
| Johnson & JohnsonXarelto | $156 | $36,83237 claims |
| PfizerEliquis | $145 | $18,84225 claims |
| AbbVieLinzess, Synthroid | $325 | $9,37852 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.
Other family in Smithville
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
- Lori LankfordNashville$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.